163 related articles for article (PubMed ID: 11205892)
1. Cocaine metabolism in human fetal and adult liver microsomes is related to cytochrome P450 3A expression.
Ladona MG; Gonzalez ML; Rane A; Peter RM; de la Torre R
Life Sci; 2000 Dec; 68(4):431-43. PubMed ID: 11205892
[TBL] [Abstract][Full Text] [Related]
2. Kinetic characteristics of norcocaine N-hydroxylation in mouse and human liver microsomes: involvement of CYP enzymes.
Pellinen P; Kulmala L; Konttila J; Auriola S; Pasanen M; Juvonen R
Arch Toxicol; 2000 Nov; 74(9):511-20. PubMed ID: 11131030
[TBL] [Abstract][Full Text] [Related]
3. Unchanged cytochrome P450 3A (CYP3A) expression and metabolism of midazolam, triazolam, and dexamethasone in mdr(-/-) mouse liver microsomes.
Perloff MD; von Moltke LL; Cotreau MM; Greenblatt DJ
Biochem Pharmacol; 1999 Jun; 57(11):1227-32. PubMed ID: 10230766
[TBL] [Abstract][Full Text] [Related]
4. Evidence for involvement of human CYP3A in the 3-hydroxylation of quinine.
Zhang H; Coville PF; Walker RJ; Miners JO; Birkett DJ; Wanwimolruk S
Br J Clin Pharmacol; 1997 Mar; 43(3):245-52. PubMed ID: 9088578
[TBL] [Abstract][Full Text] [Related]
5. Norcocaine and N-hydroxynorcocaine formation in human liver microsomes: role of cytochrome P-450 3A4.
LeDuc BW; Sinclair PR; Shuster L; Sinclair JF; Evans JE; Greenblatt DJ
Pharmacology; 1993 May; 46(5):294-300. PubMed ID: 8488174
[TBL] [Abstract][Full Text] [Related]
6. Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes.
Miyazawa M; Shindo M; Shimada T
Drug Metab Dispos; 2001 Feb; 29(2):200-5. PubMed ID: 11159812
[TBL] [Abstract][Full Text] [Related]
7. Cocaine N-demethylation and the metabolism-related hepatotoxicity can be prevented by cytochrome P450 3A inhibitors.
Pellinen P; Honkakoski P; Stenbäck F; Niemitz M; Alhava E; Pelkonen O; Lang MA; Pasanen M
Eur J Pharmacol; 1994 Jan; 270(1):35-43. PubMed ID: 8157080
[TBL] [Abstract][Full Text] [Related]
8. Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.
Ghosal A; Satoh H; Thomas PE; Bush E; Moore D
Drug Metab Dispos; 1996 Sep; 24(9):940-7. PubMed ID: 8886602
[TBL] [Abstract][Full Text] [Related]
9. Human cytochrome P450 3A (CYP3A) mediated midazolam metabolism: the effect of assay conditions and regioselective stimulation by alpha-naphthoflavone, terfenadine and testosterone.
Mäenpää J; Hall SD; Ring BJ; Strom SC; Wrighton SA
Pharmacogenetics; 1998 Apr; 8(2):137-55. PubMed ID: 10022752
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of endosulfan-alpha by human liver microsomes and its utility as a simultaneous in vitro probe for CYP2B6 and CYP3A4.
Casabar RC; Wallace AD; Hodgson E; Rose RL
Drug Metab Dispos; 2006 Oct; 34(10):1779-85. PubMed ID: 16855053
[TBL] [Abstract][Full Text] [Related]
11. Oxidative metabolism of clarithromycin in the presence of human liver microsomes. Major role for the cytochrome P4503A (CYP3A) subfamily.
Rodrigues AD; Roberts EM; Mulford DJ; Yao Y; Ouellet D
Drug Metab Dispos; 1997 May; 25(5):623-30. PubMed ID: 9152603
[TBL] [Abstract][Full Text] [Related]
12. Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes.
Lalovic B; Phillips B; Risler LL; Howald W; Shen DD
Drug Metab Dispos; 2004 Apr; 32(4):447-54. PubMed ID: 15039299
[TBL] [Abstract][Full Text] [Related]
13. Effect of age and gender on the activity of human hepatic CYP3A.
Hunt CM; Westerkam WR; Stave GM
Biochem Pharmacol; 1992 Jul; 44(2):275-83. PubMed ID: 1642641
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the involvement of CYP3A in the vitro metabolism of a new modulator of MDR in cancer chemotherapy, OC144-193, by human liver microsomes.
Guns ES; Bullock PL; Reimer ML; Dixon R; Bally M; Mayer LD
Eur J Drug Metab Pharmacokinet; 2001; 26(4):273-82. PubMed ID: 11808870
[TBL] [Abstract][Full Text] [Related]
15. In-vivo and in-vitro metabolic clearance of midazolam, a cytochrome P450 3A substrate, by the liver under normal and increased enzyme activity in rats.
Higashikawa F; Murakami T; Kaneda T; Takano M
J Pharm Pharmacol; 1999 Apr; 51(4):405-10. PubMed ID: 10385212
[TBL] [Abstract][Full Text] [Related]
16. Involvement of cytochrome P450 3A in the metabolism and covalent binding of 14C-monocrotaline in rat liver microsomes.
Reid MJ; Lamé MW; Morin D; Wilson DW; Segall HJ
J Biochem Mol Toxicol; 1998; 12(3):157-66. PubMed ID: 9522275
[TBL] [Abstract][Full Text] [Related]
17. Midazolam and triazolam biotransformation in mouse and human liver microsomes: relative contribution of CYP3A and CYP2C isoforms.
Perloff MD; von Moltke LL; Court MH; Kotegawa T; Shader RI; Greenblatt DJ
J Pharmacol Exp Ther; 2000 Feb; 292(2):618-28. PubMed ID: 10640299
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the human cytochrome P450 enzymes involved in the metabolism of dihydrocodeine.
Kirkwood LC; Nation RL; Somogyi AA
Br J Clin Pharmacol; 1997 Dec; 44(6):549-55. PubMed ID: 9431830
[TBL] [Abstract][Full Text] [Related]
19. Effect of rociverine on P450-dependent monooxygenases and its N-deethylation metabolism in rat liver microsomes.
Menicagli S; Lippi A; Criscuoli M; Gervasi PG
Biochem Pharmacol; 1993 Mar; 45(5):1097-105. PubMed ID: 8461039
[TBL] [Abstract][Full Text] [Related]
20. Model for the drug-drug interaction responsible for CYP3A enzyme inhibition. I: evaluation of cynomolgus monkeys as surrogates for humans.
Kanazu T; Yamaguchi Y; Okamura N; Baba T; Koike M
Xenobiotica; 2004 May; 34(5):391-402. PubMed ID: 15370956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
